KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growthKazuhide Nakamura, Toshiyuki Isoe|Molecular Cancer Therapeutics|2004Cited by 66